Imaging News

A new guideline on hypertrophic cardiomyopathy endorses the use of cardiac myosin inhibitors for certain patients with obstructive HCM and encourages exercise in all patients with HCM.

Despite significant decline in heart attacks since 2004, inequities in STEMI management and mortality by age, gender, income and race, speakers reported.

AI accurately predicted several measures of cardiac function from coronary angiography that would otherwise require additional tests such as echocardiography or catheterization, a speaker reported.

Patients not required to fast before cardiac catheterization reported higher overall postprocedural satisfaction with no periprocedural adverse events, a speaker reported.

ATLANTA — Intravascular ultrasound-guided PCI lowered risk for target vessel failure vs. an angiography-guided approach for patients with acute coronary syndrome, a speaker reported.

ATLANTA — Obicetrapib, a novel cholesteryl ester transfer protein inhibitor, reduced atherogenic lipoprotein particles alone or in combination with ezetimibe, according to new data from the ROSE2 trial.

ATLANTA — IVUS-guided angioplasty was superior to an angiography-guided approach for improving immediate procedural outcomes and 12-month patency in patients with symptomatic femoropopliteal artery disease, a speaker reported.

ATLANTA — Data from a small substudy with cardiac MRI suggest acoramidis may improve both cardiac mass and function for adults with symptomatic transthyretin amyloid cardiomyopathy, building on previous positive data, researchers reported.

ATLANTA — Use of a coronary sinus reducer improved chest pain symptoms and quality of life for patients with significant coronary artery disease, despite not improving myocardial blood flow, a speaker reported.

ATLANTA — Preventive PCI plus optimal medical therapy was superior to optimal medical therapy alone for patients with nonflow-limiting vulnerable coronary plaques, according to the results of the PREVENT trial.